These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 34918030)

  • 21. A quantitative study of the neuropathology of 32 sporadic and familial cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).
    Armstrong RA; Carter D; Cairns NJ
    Neuropathol Appl Neurobiol; 2012 Feb; 38(1):25-38. PubMed ID: 21696412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microglia in frontotemporal lobar degeneration with progranulin or C9ORF72 mutations.
    Sakae N; Roemer SF; Bieniek KF; Murray ME; Baker MC; Kasanuki K; Graff-Radford NR; Petrucelli L; Van Blitterswijk M; Rademakers R; Dickson DW
    Ann Clin Transl Neurol; 2019 Sep; 6(9):1782-1796. PubMed ID: 31448566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways.
    Chen-Plotkin AS; Unger TL; Gallagher MD; Bill E; Kwong LK; Volpicelli-Daley L; Busch JI; Akle S; Grossman M; Van Deerlin V; Trojanowski JQ; Lee VM
    J Neurosci; 2012 Aug; 32(33):11213-27. PubMed ID: 22895706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FTLD-TDP With and Without GRN Mutations Cause Different Patterns of CA1 Pathology.
    Mao Q; Zheng X; Gefen T; Rogalski E; Spencer CL; Rademakers R; Fought AJ; Kohler M; Weintraub S; Xia H; Mesulam MM; Bigio EH
    J Neuropathol Exp Neurol; 2019 Sep; 78(9):844-853. PubMed ID: 31361008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rare exonic variant affects GRN splicing and contributes to frontotemporal lobar degeneration.
    Wauters E; Gossye H; Frydas A; Sieben A; Van Broeckhoven C
    Neurobiol Aging; 2023 Oct; 130():61-69. PubMed ID: 37459659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.
    Papegaey A; Eddarkaoui S; Deramecourt V; Fernandez-Gomez FJ; Pantano P; Obriot H; Machala C; Anquetil V; Camuzat A; Brice A; Maurage CA; Le Ber I; Duyckaerts C; Buée L; Sergeant N; Buée-Scherrer V
    Acta Neuropathol Commun; 2016 Jul; 4(1):74. PubMed ID: 27435172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of Progranulin Expression Leads to Formation of Intranuclear TDP-43 Inclusions In Vitro: A Cell Model of Frontotemporal Lobar Degeneration.
    Zhu J; Wang N; Li X; Zheng X; Zhao J; Xia H; Mao Q
    J Neuropathol Exp Neurol; 2019 Dec; 78(12):1124-1129. PubMed ID: 31626287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Astroglial toxicity promotes synaptic degeneration in the thalamocortical circuit in frontotemporal dementia with GRN mutations.
    Marsan E; Velmeshev D; Ramsey A; Patel RK; Zhang J; Koontz M; Andrews MG; de Majo M; Mora C; Blumenfeld J; Li AN; Spina S; Grinberg LT; Seeley WW; Miller BL; Ullian EM; Krummel MF; Kriegstein AR; Huang EJ
    J Clin Invest; 2023 Mar; 133(6):. PubMed ID: 36602862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cortical degeneration in frontotemporal lobar degeneration with TDP-43 proteinopathy caused by progranulin gene mutation.
    Armstrong RA
    Int J Neurosci; 2014 Dec; 124(12):894-903. PubMed ID: 24494724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathological 25 kDa C-Terminal Fragments of TDP-43 Are Present in Lymphoblastoid Cell Lines and Extracellular Vesicles from Patients Affected by Frontotemporal Lobar Degeneration and Neuronal Ceroidolipofuscinosis Carrying a
    Cimini S; Bellini S; Saraceno C; Benussi L; Ghidoni R; Giliani SC; Puoti G; Canafoglia L; Giaccone G; Rossi G
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
    Bieniek KF; Murray ME; Rutherford NJ; Castanedes-Casey M; DeJesus-Hernandez M; Liesinger AM; Baker MC; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2013 Feb; 125(2):289-302. PubMed ID: 23053135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.
    Nicholson AM; Finch NA; Wojtas A; Baker MC; Perkerson RB; Castanedes-Casey M; Rousseau L; Benussi L; Binetti G; Ghidoni R; Hsiung GY; Mackenzie IR; Finger E; Boeve BF; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Rademakers R
    J Neurochem; 2013 Sep; 126(6):781-91. PubMed ID: 23742080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis.
    Armstrong RA; Ellis W; Hamilton RL; Mackenzie IR; Hedreen J; Gearing M; Montine T; Vonsattel JP; Head E; Lieberman AP; Cairns NJ
    J Neural Transm (Vienna); 2010 Feb; 117(2):227-39. PubMed ID: 20012109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The heritability and genetics of frontotemporal lobar degeneration.
    Rohrer JD; Guerreiro R; Vandrovcova J; Uphill J; Reiman D; Beck J; Isaacs AM; Authier A; Ferrari R; Fox NC; Mackenzie IR; Warren JD; de Silva R; Holton J; Revesz T; Hardy J; Mead S; Rossor MN
    Neurology; 2009 Nov; 73(18):1451-6. PubMed ID: 19884572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human genetics as a tool to identify progranulin regulators.
    Nicholson AM; Finch NA; Rademakers R
    J Mol Neurosci; 2011 Nov; 45(3):532-7. PubMed ID: 21626010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.
    Irwin DJ; Cairns NJ; Grossman M; McMillan CT; Lee EB; Van Deerlin VM; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2015 Apr; 129(4):469-91. PubMed ID: 25549971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of Tmem106b exacerbates FTLD pathologies and causes motor deficits in progranulin-deficient mice.
    Zhou X; Brooks M; Jiang P; Koga S; Zuberi AR; Baker MC; Parsons TM; Castanedes-Casey M; Phillips V; Librero AL; Kurti A; Fryer JD; Bu G; Lutz C; Dickson DW; Rademakers R
    EMBO Rep; 2020 Oct; 21(10):e50197. PubMed ID: 32761777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter DNA methylation regulates progranulin expression and is altered in FTLD.
    Banzhaf-Strathmann J; Claus R; Mücke O; Rentzsch K; van der Zee J; Engelborghs S; De Deyn PP; Cruts M; van Broeckhoven C; Plass C; Edbauer D
    Acta Neuropathol Commun; 2013 May; 1():16. PubMed ID: 24252647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing progranulin levels and blockade of the ERK1/2 pathway: upstream and downstream strategies for the treatment of progranulin deficient frontotemporal dementia.
    Alquezar C; Esteras N; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):386-403. PubMed ID: 25624003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneous ribonuclear protein A3 (hnRNP A3) is present in dipeptide repeat protein containing inclusions in Frontotemporal Lobar Degeneration and Motor Neurone disease associated with expansions in C9orf72 gene.
    Davidson YS; Flood L; Robinson AC; Nihei Y; Mori K; Rollinson S; Richardson A; Benson BC; Jones M; Snowden JS; Pickering-Brown S; Haass C; Lashley T; Mann DMA
    Acta Neuropathol Commun; 2017 Apr; 5(1):31. PubMed ID: 28431575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.